Think

Search This Blog

F.D.A. advisers will weigh in on Covid shots by Novavax, a latecomer in the vaccine race.

June 07, 2022

Get link
Facebook
X
Pinterest
Email
Other Apps

BY CARL ZIMMER AND REBECCA ROBBINS | NYTimes Health | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

For Older Unmarried Couples, Caregiving Obligations Can Be Murky

What should be expected of an intimate partner when a companion suffers a health crisis? Seniors and their families increasingly confront the question. Paula Span | NYTimes Health | Disclosure

A Trans Researcher’s Pursuit of Better Data on Detransition

Kinnon MacKinnon leads the world’s largest study on people who stop or reverse their gender transitions, a group embroiled in intense political fights. Azeen Ghorayshi | NYTimes Health | Disclosure

He’s the F.D.A.’s Cancer Chief, Not a Fortune Teller

Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency. Gina Kolata | NYTimes Health | Disclosure

Why Heat Waves of the Future May Be Even Deadlier Than Believed

The body’s cooling defenses fail at lower “wet bulb” temperatures than scientists had estimated. Clayton Dalton | NYTimes Health | Disclosure

A.I. Chatbots Defeated Doctors at Diagnosing Illness

A small study found ChatGPT outdid human physicians when assessing medical case histories, even when those doctors were using a chatbot. Gina Kolata | NYTimes Health | Disclosure

F.D.A. advisers will weigh in on Covid shots by Novavax, a latecomer in the vaccine race.

Comments

Post a Comment